Page last updated: 2024-08-24

atorvastatin and Rhabdomyolysis

atorvastatin has been researched along with Rhabdomyolysis in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (4.76)	18.2507
2000's	35 (41.67)	29.6817
2010's	35 (41.67)	24.3611
2020's	10 (11.90)	2.80

Authors

Authors	Studies
Asada, M; Bando, T; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kondo, Y; Miyata, K; Nakamoto, A; Niimura, T; Okada, N; Takechi, K; Tasaki, Y; Yagi, K; Yanagawa, H; Yoshioka, T; Zamami, Y	1
Ares Castro-Conde, B; Cachafeiro Pin, AI; Pérez Castro, A; Villaverde Piñeiro, L	1
Cui, W; Li, C; Lu, X; Teng, W; Wang, W	1
Hennersdorf, F; Intert, E; Knop, K; Krause, M; Rosenkranz, T	1
Montastruc, JL	1
Gómez-Flores, SS; Medina-Romero, J; Reyes-Álvarez, FJ; Toledo-Salinas, O	1
Bouchard, J; De La Pena, N; Oleksiuk, LM	1
Cai, W; Dai, Y; Han, B; Jiao, Z; Jin, Z; Li, S; Lin, H; Ma, G; Xiang, X; Yu, Y	1
Han, X; Huang, H; Ji, Y; Liu, Y; Luo, Z; Sun, W; Wang, G; Yang, T; Yu, G	1
Abudalou, M; Al Sbihi, A; Mohamed, AS; Vega, EA	1
Aleta, M; Batra, J; Buttar, RS; Kreimerman, J; Melamed, ML	1
Acar, D; Açıkgöz, K; Çağlar, A; Cander, B; Gülpembe, M; Özdamar, EN; Yıldız, CG	1
Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T	1
Dalugama, C; Kularatne, SAM; Pathirage, M	1
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL	1
Mohamed, MFH; Saeed, AAM; Salameh, OK	1
Abushahin, A; Hasan, S; Kilani, A; Prayson, R	1
Baggett, MC; Nykamp, D	1
Arvikar, SL; Clement, NF; Freeman, MW; Goldstein, RH; Guidon, AC; Singh, AK	1
Eshraghian, A; Kamyab, AA	1
Panchangam, V	1
Also, MA; Bastida, C; Letang, E; Miró, JM; Pericas, JM; Tuset, M	1
Horoshko, OM; Zamors'kyĭ, II; Zeleniuk, VH	1
Hunter, ML; Mahvan, TD; Mlodinow, SG; Onysko, MK; Vandiver, JW	1
Petruccelli, S; Rebelos, E; Rosada, J; Taddei, M	1
Fabiny, A	1
Caran, T; Cibicek, N; Cibickova, L; Dobias, M; Ondra, P; Vorisek, V	1
Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM	1
Chang, HJ; Hsiao, SH; Hsieh, TH; Kao, SM; Wu, TJ; Yeh, PY	1
Ambapkar, SN; Dwivedy, A; Shetty, N	1
Huynh, GA; Lee, AJ	1
Dunphy, L; Morhij, R; Tucker, S	1
Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C	1
Glueck, CJ; Goldenberg, N; Khan, NA; Rawal, B; Wang, P; Yeramaneni, S	1
Abel, T; Fehér, J	1
Antoine, JC; Estour, B; Germain, N; Khalfallah, Y; Leca, V; Vergely, N	1
Akiyoshi, T; Anami, S; Matsuyama, K; Matzno, S; Nakabayashi, T; Nishiguchi, T	1
Bate, A; Edwards, IR; Hägg, S; Strandell, J	1
Clarkson, MR; Conlon, PJ; Leavey, SF; Magee, CN; Medani, SA	1
Anetseder, M; Hager, M; Metterlein, T; Roewer, N; Schuster, F; Tadda, L	1
Bonbled, F; Hantson, P; Huberlant, V; Montiel, V; Vincent, MF	1
Almond, A; Donaldson, K; Isles, C; Robertson, S; Teckchandani, S	1
Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE	1
Åsberg, A; Bogsrud, MP; Hermann, M; Retterstøl, K; Skottheim, IB	1
Abraham, G; Gnanaraj, A; Sankardas, MA; Victor, SM	1
Bhome, R; Penn, H	1
Fenech, ME; Mackay, JW; Myint, KS	1
Cannon, CS	1
Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S	1
Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM	1
Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A	1
Lewin, JJ; Nappi, JM; Taylor, MH	1
Bernstein, D; Chin, C; Gamberg, P; Luikart, H; Miller, J	1
Bendahan, D; Bernard, V; Cozzone, PJ; Figarella-Branger, D; Guis, S; Kozak-Ribbens, G; Lando, A; Mattei, JP; Pellissier, JF; Treffouret, S	1
Bokhart, GH; Jones, RJ; Sipe, BE	1
Gill, MJ; Mah Ming, JB	1
Chan, KH; Chau, E; Lai, KC; Wai-Hung Shek, T; Wong, WM	1
Das, V; Shrivastava, R; Singh, S	1
Karch, AM	1
Bäcklund, T; Kahri, J; Kivistö, KT; Valkonen, M; Vuoristo, M	1
Satish, B; Unnikrishnan, D	1
Ravnskov, U; Rosch, PJ; Sutter, MC	1
McKenney, JM	1
Phillips, PS	1
Ho, L; Levidiotis, V; Lim, AK	1
Edwards, C; Gladding, PA; Kerr, A	1
Chiesa, G; Cippone, V; Conte Camerino, D; De Luca, A; De Vito, D; Didonna, MP; Frigeri, A; Nicchia, GP; Pierno, S; Pisoni, M; Rizzo, C; Scanziani, E; Sirtori, C; Svelto, M	1
Boyd, IW; O'Shea, JM; Ronaldson, KJ	1
Evans, M; Golomb, B	1
Alsheikh-Ali, AA; Karas, RH	1
Jose, J; Saravu, K; Shastry, BA	1
Rosenberg, L; Uretsky, S	1
Amado Señaris, JA; García Unzueta, MT; Otero Martínez, M; Piedra León, M	1
Dal Pan, G; McAdams, M; Staffa, J	1
Connor, WE; Duell, PB; Illingworth, DR	1
Dietz, BL; Oberg, KC	1
Balog, DL; Cheigh, JS; Maltz, HC	1
Chik, G; Christ, ER; Crook, MA; Lumb, PJ; Semra, Y; Wierzbicki, AS	1
El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C	1
Castro, JG; Gutierrez, L	1
Bellosta, S; Corsini, A; Paoletti, R	1

Reviews

4 review(s) available for atorvastatin and Rhabdomyolysis

Article	Year
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8 Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Daptomycin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; United States; United States Food and Drug Administration	2022
High-Intensity Atorvastatin-Induced Rhabdomyolysis in an Elderly Patient With NSTEMI: A Case Report and Review of the Literature. Journal of pharmacy practice, 2017, Volume: 30, Issue:6 Topics: Aged, 80 and over; Atorvastatin; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Non-ST Elevated Myocardial Infarction; Rhabdomyolysis	2017
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. The American journal of cardiology, 2005, Aug-22, Volume: 96, Issue:4A Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome	2005
Pharmacological interactions of statins. Atherosclerosis. Supplements, 2002, Volume: 3, Issue:1 Topics: Atorvastatin; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Tolerance; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Muscular Diseases; Pyrroles; Rhabdomyolysis	2002

Trials

3 trial(s) available for atorvastatin and Rhabdomyolysis

Article	Year
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA, 2016, Apr-19, Volume: 315, Issue:15 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors	2016
Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? Metabolism: clinical and experimental, 2009, Volume: 58, Issue:2 Topics: Atorvastatin; Cholesterol, LDL; Creatine Kinase; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2009
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy. Molecular diagnosis & therapy, 2011, Aug-01, Volume: 15, Issue:4 Topics: Adult; Aged; Atorvastatin; Biomarkers; Creatine Kinase; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pyrroles; Rhabdomyolysis; Sensitivity and Specificity	2011

Other Studies

77 other study(ies) available for atorvastatin and Rhabdomyolysis

Article	Year
Atorvastatin induced rhabdomyolysis: Utility of determining genetic polymorphisms. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2021, 12-25, Volume: 46, Issue:2 Topics: Atorvastatin; Humans; Polymorphism, Genetic; Rhabdomyolysis	2021
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report. BMC infectious diseases, 2022, Apr-11, Volume: 22, Issue:1 Topics: Aged; Atorvastatin; Female; Guanine; Hepatitis B; Humans; Rhabdomyolysis; Rosuvastatin Calcium	2022
[Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat]. Innere Medizin (Heidelberg, Germany), 2022, Volume: 63, Issue:11 Topics: Atorvastatin; Cobicistat; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis	2022
Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. British journal of clinical pharmacology, 2023, Volume: 89, Issue:8 Topics: Adult; Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pharmacovigilance; Rhabdomyolysis; Simvastatin	2023
[Severe rhabdomyolysis associated with atorvastatin. Case report]. Revista medica del Instituto Mexicano del Seguro Social, 2023, Mar-01, Volume: 61, Issue:2 Topics: Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Rhabdomyolysis; Risk Factors	2023
Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review. Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:6 Topics: Aged; Anti-Infective Agents, Urinary; Anticholesteremic Agents; Atorvastatin; Humans; Levofloxacin; Male; Rhabdomyolysis	2019
Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 119 Topics: Aged; Atorvastatin; Computer Simulation; Drug Interactions; Female; Humans; Male; Middle Aged; Models, Biological; Muscles; Rhabdomyolysis	2019
Prediction of the pharmacokinetics and pharmacodynamics of topiroxostat in humans by integrating the physiologically based pharmacokinetic model with the drug-target residence time model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121 Topics: Adult; Atorvastatin; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Evaluation Studies as Topic; Humans; Lactones; Middle Aged; Nitriles; Organic Anion Transporters; Pyridines; Rhabdomyolysis	2020
Colchicine-induced rhabdomyolysis: a review of 83 cases. BMJ case reports, 2021, Jul-21, Volume: 14, Issue:7 Topics: Aged; Atorvastatin; Colchicine; Coronary Artery Bypass; Humans; Male; Pericardial Effusion; Rhabdomyolysis	2021
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. Journal of general internal medicine, 2017, Volume: 32, Issue:10 Topics: Acute Kidney Injury; Aged, 80 and over; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis; Sitagliptin Phosphate; Vitamin D	2017
The reno-protective effects of atorvastatin in crush syndrome and rhabdomyolysis:is there a dilemma? Turkish journal of medical sciences, 2017, Dec-19, Volume: 47, Issue:6 Topics: Animals; Atorvastatin; Blood Urea Nitrogen; Creatine Kinase; Creatinine; Crush Syndrome; Female; Kidney; Myoglobin; Protective Agents; Random Allocation; Rats; Rats, Wistar; Rhabdomyolysis	2017
Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. Toxicology letters, 2018, Volume: 291 Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Atorvastatin; Buthionine Sulfoximine; Ciprofloxacin; Creatine Kinase; Disease Models, Animal; Drug Interactions; Female; Glutathione Synthase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Rhabdomyolysis	2018
Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report. Journal of medical case reports, 2018, May-22, Volume: 12, Issue:1 Topics: Acute Kidney Injury; Adult; Atorvastatin; Creatinine; Cytochrome P-450 CYP2C8 Inhibitors; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Polypharmacy; Rhabdomyolysis; Risk Factors	2018
Clinical features related to statin-associated muscle symptoms. Muscle & nerve, 2019, Volume: 59, Issue:5 Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People	2019
Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death. The American journal of case reports, 2019, May-18, Volume: 20 Topics: Acute Kidney Injury; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Fatal Outcome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis	2019
When Statins Cause an Autoimmune Response: A Report of a Severe Case of Rhabdomyolysis. The American journal of medicine, 2020, Volume: 133, Issue:1 Topics: Aged; Atorvastatin; Autoantibodies; Autoimmune Diseases; Azathioprine; Creatine Kinase; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Immunologic Factors; Male; Muscle, Skeletal; Muscular Diseases; Myoglobin; Necrosis; Prednisone; Rhabdomyolysis; Severity of Illness Index	2020
Statin-Associated Bilateral Foot Myopathy. Journal of pharmacy practice, 2020, Volume: 33, Issue:6 Topics: Adult; Atorvastatin; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscular Diseases; Rhabdomyolysis	2020
Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia. The New England journal of medicine, 2019, Jul-18, Volume: 381, Issue:3 Topics: Aged; Atorvastatin; Autoimmune Diseases; Carotid Artery, Internal; Cerebral Infarction; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Angiography; Muscle Weakness; Muscle, Skeletal; Myoglobinuria; Myositis; Rhabdomyolysis; Tomography, X-Ray Computed	2019
Rhabdomyolysis developing secondary to atorvastatin therapy in a patient with liver cirrhosis. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:7 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Liver Cirrhosis; Pyrroles; Rhabdomyolysis	2013
Statin-associated acute interstitial nephritis and rhabdomyolysis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:3 Topics: Acute Kidney Injury; Atorvastatin; Glucocorticoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nephritis, Interstitial; Prednisolone; Pyrroles; Renal Dialysis; Rhabdomyolysis; Time Factors; Treatment Outcome	2014
[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?]. Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:9 Topics: Antiretroviral Therapy, Highly Active; Atorvastatin; Chemical and Drug Induced Liver Injury; Comorbidity; Contraindications; Cost-Benefit Analysis; Cytochrome P-450 CYP3A Inhibitors; Drug Substitution; Drug Synergism; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubular Necrosis, Acute; Middle Aged; Rhabdomyolysis; Ritonavir; Simvastatin	2014
[Renoprotective efficacy of different doses of statins in experimental acute renal failure]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2014, Volume: 60, Issue:2 Topics: Acute Kidney Injury; Administration, Topical; Animals; Atorvastatin; Creatine Kinase; Diuresis; Glomerular Filtration Rate; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lovastatin; Pyrroles; Rats; Rhabdomyolysis; Simvastatin; Stomach; Urodynamics	2014
Statin adverse effects: sorting out the evidence. The Journal of family practice, 2014, Volume: 63, Issue:9 Topics: Atorvastatin; Clinical Trials as Topic; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Practice; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pyrroles; Rhabdomyolysis; Risk Adjustment; Ubiquinone; Vitamins	2014
Protocols cure diseases, not patients: flaccid paresis in post-NSTEMI statin treatment. BMJ case reports, 2015, Apr-22, Volume: 2015 Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Paresis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Rhabdomyolysis; Stents	2015
Ask the doctor. I am 61 and had been on atorvastatin for 10 years with no problems. Recently, I've had disabling muscle pain with both the generic atorvastatin and the brand-name version, Lipitor. My doctor says that I can no longer take statin drugs. Harvard women's health watch, 2014, Volume: 22, Issue:3 Topics: Anticholesteremic Agents; Atorvastatin; Female; Health Behavior; Heptanoic Acids; Humans; Middle Aged; Muscle, Skeletal; Pyrroles; Rhabdomyolysis; Stroke	2014
Multi-drug intoxication fatality involving atorvastatin: A case report. Forensic science international, 2015, Volume: 257 Topics: Acute Kidney Injury; Aged; Alcoholics; Anthraquinones; Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; Drug Overdose; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Piperazines; Rhabdomyolysis; Suicide; Vasodilator Agents; Verapamil	2015
Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review. Journal of clinical pharmacy and therapeutics, 2016, Volume: 41, Issue:5 Topics: Aged; Atorvastatin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Humans; Rhabdomyolysis	2016
Statin-Induced Rhabdomyolysis. The Journal of the Association of Physicians of India, 2016, Volume: 64, Issue:7 Topics: Aged; Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis	2016
Rhabdomyolysis-induced compartment syndrome secondary to atorvastatin and strenuous exercise. BMJ case reports, 2017, Mar-16, Volume: 2017 Topics: Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Compartment Syndromes; Exercise; Fasciotomy; Humans; Male; Middle Aged; Pain; Postoperative Complications; Ramipril; Rhabdomyolysis; Thigh	2017
Rhabdomyolysis with atorvastatin and fusidic acid. Postgraduate medical journal, 2008, Volume: 84, Issue:992 Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteomyelitis; Pyrroles; Rhabdomyolysis	2008
[Statin therapy and muscle disorders]. Orvosi hetilap, 2009, Feb-08, Volume: 150, Issue:6 Topics: Atorvastatin; Biological Availability; Cytochrome P-450 Enzyme System; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Muscle, Skeletal; Muscular Diseases; Pravastatin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2009
[Metabolic rhabdomyolysis during statin therapy]. La Revue de medecine interne, 2009, Volume: 30, Issue:8 Topics: Atorvastatin; Carnitine O-Palmitoyltransferase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyridines; Pyrroles; Rhabdomyolysis	2009
Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:6 Topics: Alendronate; Animals; Apoptosis; Atorvastatin; Bone Density Conservation Agents; Caspases; Cell Line; Diphosphonates; DNA Fragmentation; Drug Synergism; Enzyme Activation; Etidronic Acid; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myoblasts, Skeletal; Pyrroles; Rats; Rhabdomyolysis; Risedronic Acid	2009
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. British journal of clinical pharmacology, 2009, Volume: 68, Issue:3 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Atorvastatin; Azithromycin; Databases, Factual; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Rhabdomyolysis; Simvastatin	2009
Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:5 Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteomyelitis; Pyrroles; Rhabdomyolysis; Severity of Illness Index	2010
Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals. Cardiovascular therapeutics, 2010, Volume: 28, Issue:6 Topics: Animals; Atorvastatin; Biopsy; Calcium; Electric Stimulation; Female; Gemfibrozil; Genotype; Heptanoic Acids; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Isometric Contraction; Male; Malignant Hyperthermia; Muscle, Skeletal; Phenotype; Pyrroles; Rhabdomyolysis; Simvastatin; Swine; Time Factors	2010
Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management. Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:8 Topics: Adult; Atorvastatin; Colchicine; Critical Care; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Overdose; Female; Heptanoic Acids; Humans; Multiple Organ Failure; Propofol; Pyrroles; Rhabdomyolysis	2010
Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Interactions; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis	2010
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. Praxis, 2011, Mar-02, Volume: 100, Issue:5 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; Coronary Artery Bypass, Off-Pump; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluconazole; Heptanoic Acids; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Postoperative Complications; Pyrroles; Rhabdomyolysis	2011
Hypernatremia due to rhabdomyolysis in a patient on statin. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:5 Topics: Anterior Wall Myocardial Infarction; Atorvastatin; Creatine Kinase, MB Form; Creatinine; Fatal Outcome; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypernatremia; Male; Middle Aged; Peritoneal Dialysis; Pyrroles; Rhabdomyolysis	2011
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:5 Topics: Aged; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Pyrazines; Pyrroles; Rhabdomyolysis; Sitagliptin Phosphate; Treatment Outcome; Triazoles	2012
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin. British journal of hospital medicine (London, England : 2005), 2012, Volume: 73, Issue:2 Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin	2012
Statin-induced rhabdomyolysis and dermatomyositis: a rare combination. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:8 Topics: Atorvastatin; Comorbidity; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2012
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. International journal of clinical pharmacy, 2012, Volume: 34, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pantoprazole; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Pyrroles; Renal Dialysis; Rhabdomyolysis; Risk Factors; Treatment Outcome	2012
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid]. La Revue de medecine interne, 2013, Volume: 34, Issue:1 Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections	2013
Severe colchicine intoxication in a renal transplant recipient on cyclosporine. Transplantation proceedings, 2012, Volume: 44, Issue:9 Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome	2012
Rhabdomyolysis with concurrent atorvastatin and diltiazem. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:10 Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2002
The HMG Co-A reductase inhibitors ('statins') and myotoxic effects. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2002, Volume: 92, Issue:8 Topics: Atorvastatin; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Muscular Diseases; Myositis; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin	2002
Efficacy and safety of atorvastatin after pediatric heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2002, Volume: 21, Issue:11 Topics: Adolescent; Atorvastatin; Child; Female; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Postoperative Period; Pyrroles; Retrospective Studies; Rhabdomyolysis	2002
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility. Arthritis and rheumatism, 2003, Apr-15, Volume: 49, Issue:2 Topics: Atorvastatin; Cholinesterase Inhibitors; Disease Susceptibility; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Malignant Hyperthermia; Middle Aged; Pain; Pyrroles; Rhabdomyolysis	2003
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:6 Topics: Atorvastatin; Clarithromycin; Drug Interactions; Esomeprazole; Female; Heart Block; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Rhabdomyolysis	2003
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS patient care and STDs, 2003, Volume: 17, Issue:5 Topics: Adult; Anti-Bacterial Agents; Atorvastatin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Male; Pyrimidinones; Pyrroles; Rhabdomyolysis; Ritonavir	2003
Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy. Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:8 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Colon; Colonoscopy; Cyclosporine; Cytomegalovirus Infections; Drug Interactions; Heart Transplantation; Heptanoic Acids; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrroles; Rhabdomyolysis; Treatment Outcome	2004
Formulary conversion programs: the need for patient-specific risk assessment. MedGenMed : Medscape general medicine, 2004, Sep-14, Volume: 6, Issue:3 Topics: Aged; Atorvastatin; Cyclosporine; Drug Interactions; Female; Formularies as Topic; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Postoperative Care; Pyrroles; Rhabdomyolysis; Risk Assessment; Simvastatin	2004
The grapefruit challenge: the juice inhibits a crucial enzyme, with possibly fatal consequences. The American journal of nursing, 2004, Volume: 104, Issue:12 Topics: Anticholesteremic Agents; Atorvastatin; Beverages; Citrus paradisi; Food-Drug Interactions; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2004
Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. European journal of clinical pharmacology, 2005, Volume: 60, Issue:12 Topics: Antifungal Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Fatal Outcome; Fluconazole; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mycoses; Pyrroles; Rhabdomyolysis	2005
Exertion-induced rhabdomyolysis in a patient on statin therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:1 Topics: Acute Kidney Injury; Atorvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipidemias; Long-Term Care; Male; Middle Aged; Physical Exertion; Pyrroles; Rhabdomyolysis; Risk Assessment; Severity of Illness Index	2005
Intensive lipid lowering with atorvastatin in coronary disease. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Atorvastatin; Cardiovascular Diseases; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mortality; Pyrroles; Rhabdomyolysis	2005
How common is rhabdomyolysis in patients receiving lipid-lowering therapy? Nature clinical practice. Cardiovascular medicine, 2005, Volume: 2, Issue:3 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Creatine Kinase; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Middle Aged; Pravastatin; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States	2005
Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation. Internal medicine journal, 2006, Volume: 36, Issue:7 Topics: Acute Kidney Injury; Anticholesteremic Agents; Atorvastatin; Disseminated Intravascular Coagulation; Drug Synergism; Female; Hemolytic-Uremic Syndrome; Heptanoic Acids; Humans; Middle Aged; Muscle Relaxants, Central; Pyrroles; Quinine; Rhabdomyolysis; Sleep-Wake Transition Disorders	2006
Media report of rare rhabdomyolysis cases seems to have triggered reluctance among some New Zealanders to use statins. The New Zealand medical journal, 2006, Sep-08, Volume: 119, Issue:1241 Topics: Anticholesteremic Agents; Atorvastatin; Health Education; Health Knowledge, Attitudes, Practice; Heptanoic Acids; Humans; Hypercholesterolemia; Mass Media; New Zealand; Pyrroles; Rhabdomyolysis; Simvastatin	2006
Atorvastatin for stroke prevention. The Medical letter on drugs and therapeutics, 2006, Sep-11, Volume: 48, Issue:1243 Topics: Atorvastatin; Cerebral Hemorrhage, Traumatic; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Muscular Diseases; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Stroke; Sulfonamides; Time Factors	2006
Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. British journal of pharmacology, 2006, Volume: 149, Issue:7 Topics: Action Potentials; Animals; Aquaporin 4; Atorvastatin; Body Weight; Chloride Channels; Dose-Response Relationship, Drug; Eating; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Diseases; Lipids; Male; Membrane Potentials; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle, Skeletal; Muscular Diseases; Myosin Heavy Chains; Organ Size; Pyrroles; Rats; Rats, Wistar; Rhabdomyolysis; Time Factors	2006
Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Drug safety, 2006, Volume: 29, Issue:11 Topics: Atorvastatin; Australia; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Rhabdomyolysis; Risk Factors; Simvastatin	2006
Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Drug safety, 2006, Volume: 29, Issue:12 Topics: Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Rhabdomyolysis; Risk Factors; Simvastatin	2006
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). The American journal of cardiology, 2007, Feb-01, Volume: 99, Issue:3 Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Prescriptions; Drug Therapy, Combination; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver Diseases; Lovastatin; Niacin; Pravastatin; Prevalence; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States; United States Food and Drug Administration	2007
Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Apr-01, Volume: 64, Issue:7 Topics: Adolescent; Atorvastatin; Early Diagnosis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Male; Nephrotic Syndrome; Pyrroles; Rhabdomyolysis	2007
Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials". Circulation, 2007, Jul-03, Volume: 116, Issue:1 Topics: Atorvastatin; Biomarkers; Creatine Kinase, MM Form; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Pyrroles; Randomized Controlled Trials as Topic; Rhabdomyolysis	2007
[Rhabdomyolysis associated to combined ezetimibe-statin treatment]. Revista clinica espanola, 2007, Volume: 207, Issue:8 Topics: Adult; Alcohol Drinking; Anticholesteremic Agents; Atorvastatin; Azetidines; Drug Therapy, Combination; Ezetimibe; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Time Factors	2007
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:3 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Atorvastatin; Child; Child, Preschool; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Infant; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Retrospective Studies; Rhabdomyolysis; Simvastatin; United States; United States Food and Drug Administration	2008
Rhabdomyolysis after taking atorvastatin with gemfibrozil. The American journal of cardiology, 1998, Feb-01, Volume: 81, Issue:3 Topics: Adult; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Female; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hypertriglyceridemia; Hypolipidemic Agents; Pyrroles; Rhabdomyolysis	1998
Judicious evaluation of adverse drug reactions: inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced muscle injury. Pharmacotherapy, 1999, Volume: 19, Issue:2 Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Atorvastatin; Diagnostic Errors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pyrroles; Rhabdomyolysis; Simvastatin	1999
Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:11 Topics: Anticholesteremic Agents; Atorvastatin; Cadaver; Clinical Enzyme Tests; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Pyrroles; Rhabdomyolysis	1999
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. QJM : monthly journal of the Association of Physicians, 1999, Volume: 92, Issue:7 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Prospective Studies; Pyrroles; Rhabdomyolysis; Simvastatin; Triglycerides	1999
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy. The American journal of medicine, 2000, Volume: 109, Issue:1 Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries	2000
. . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Research initiative, treatment action : RITA, 2000, Volume: 6, Issue:4 Topics: Anti-HIV Agents; Anti-Infective Agents; Antineoplastic Agents; Atorvastatin; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Heptanoic Acids; HIV Infections; Humans; Pyrroles; Rhabdomyolysis	2000
Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. The American journal of medicine, 2002, Apr-15, Volume: 112, Issue:6 Topics: Acute Kidney Injury; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delavirdine; Drug Interactions; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mixed Function Oxygenases; Pyrroles; Rhabdomyolysis	2002